ProCE Banner Activity

Having Culturally Competent Conversations With Your South Asian Patients With IBD

PDF

Use this downloadable resource to help you have culturally competent discussions with your South Asian Patients with IBD.

Released: July 31, 2023

Share

Faculty

Tauseef Ali

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Tina Aswani-Omprakash

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Provided by

Provided by Clinical Care Options, LLC in partnership with the South Asian IBD Alliance.

ProCE Banner
ProCE Banner

Supporters

This activity is supported by independent educational grants from Takeda Pharmaceuticals U.S.A., Inc., Janssen Pharmaceutical Companies, Lilly, Bristol Myers Squibb (BMS), and Hollister, Inc.

Bristol Myers Squibb

Hollister, Inc.

Janssen Pharmaceutical Companies

Lilly

Takeda Pharmaceuticals U.S.A., Inc.

Disclosure

Primary Author

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Tauseef Ali, MD, FACG, AGAF: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Janssen, Takeda.

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Tina Aswani-Omprakash, MPH: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Iterative Health Genentech/Roche, Hollister, Janssen, Pfizer, Takeda, Tillots.